← Back to news
Clinical trialCLINICALTRIALSTuesday, April 28, 2026 · Today

New Clinical Trial: Bridges2Scale: Testing Implementation Strategies (NCT06347146)

WHY IT MATTERS

This trial is testing implementation strategies for HIV/AIDS support programs in adolescents and youth in Uganda, which could improve how effective HIV care and education reaches young people in resource-limited settings.

Researchers are testing two different ways to bring a program called Bridges to more schools in Uganda. Bridges helps young people (ages 11-17) who are living with HIV/AIDS learn about their health and get support. This study will compare whether a standard approach or an enhanced approach works better at getting the program into 48 schools in the Greater Masaka region.

NCT ID: NCT06347146 Status: ACTIVE_NOT_RECRUITING Conditions: HIV/AIDS Phase: NA Enrollment: 1440 Sponsor: Washington University School of Medicine Summary: The goal of this clinical trial is to compare two multifaceted strategies (standard vs enhanced) for scaling Bridges in a two-arm Hybrid III effectiveness-implementation cluster randomized controlled trial (RCT) in adolescent and youths affected by AIDS \[AYaAIDS\] (ages 11-17 years) from 48 schools in the Greater Masaka region of Uganda. The main aims of the clinical trial are: Aim 1. Compare the implementation effectiveness of the standard implementation strategy vs. an enhanced implementation

Read the original at clinicaltrials
hiv/aidsadolescentsimplementation scienceugandayouth health

Related conditions

Hyperimmunoglobulinemia D with periodic fever